P827: Expanded chromosomal microarray comprising screening for spinal muscular atrophy and monogenic diseases in prenatal diagnosis

P827: Expanded chromosomal microarray comprising screening for spinal muscular atrophy and monogenic diseases in prenatal diagnosis

Saved in:

Bibliographic Details
Main Authors:	Xiaorui Luan, Songchang Chen, Chenming Xu
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Genetics in Medicine Open
Online Access:	http://www.sciencedirect.com/science/article/pii/S294977442501235X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prenatal carrier screening for spinal muscular atrophy among pregnant Thai women
by: Chayada Tangshewinsirikul, et al.
Published: (2025-06-01)

Carrier Screening and Prenatal Diagnosis for Spinal Muscular Atrophy in Ningde City, Fujian Province
by: JiaoJiao Lu, et al.
Published: (2025-02-01)

Outcomes of genetic testing and prenatal diagnosis of spinal muscular atrophy in Jordan
by: Mohammad Shboul, et al.
Published: (2025-12-01)

Safety through design: Expanding options for spinal muscular atrophy gene therapy
by: Ewout J.N. Groen, et al.
Published: (2025-09-01)

Spinal Muscular Atrophy Diagnosed by Newborn Screening
by: Matias Lopez-Chacon, et al.
Published: (2019-12-01)

Biomarkers in spinal muscular atrophy
by: Liping Yan, et al.
Published: (2025-07-01)

Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease/spinal bulbar muscular atrophy.
by: Kaiguo Mo, et al.
Published: (2010-09-01)

Reviews of spinal muscular atrophy in Taiwan
by: Yung-Hsiu Lu, et al.
Published: (2024-12-01)

Euglycemic Ketoacidosis in Spinal Muscular Atrophy
by: Dimitrios Stoimenis, et al.
Published: (2019-01-01)

P699: Understanding prenatal chromosomal abnormalities: Importance of both chromosomal and microarray aberrations
by: Robert Best, et al.
Published: (2025-01-01)

P809: Prenatal chromosomal microarray classification and reporting among screen positive cases in California
by: Sona Saha, et al.
Published: (2025-01-01)

Molecular mechanism of neurodegeneration in spinal muscular atrophy
by: A. I. Vlasenko, et al.
Published: (2024-09-01)

Proximal spinal muscular atrophy 5q
by: article Editorial
Published: (2020-12-01)

Clinical and biochemical polymorphism of spinal muscular atrophy
by: M. G. Sokolova, et al.
Published: (2017-03-01)

Acute Onset Infantile Spinal Muscular Atrophy
by: J Gordon Millichap
Published: (2001-07-01)

MicroRNAs as Biomarkers in Spinal Muscular Atrophy
by: Maruša Barbo, et al.
Published: (2024-10-01)

The First Registered Type 0 Spinal Muscular Atrophy Patient in Latvia: Call for Change in Prenatal Diagnostic Procedures
by: Tīna Luīze Čupāne, et al.
Published: (2023-01-01)

Socioeconomic efficiency of neonatal screening for spinal muscular atrophy in the Russian Federation
by: I. A. Komarov, et al.
Published: (2023-10-01)

Results of the Hungarian Newborn Screening Pilot Program for Spinal Muscular Atrophy
by: Krisztina Hegedűs, et al.
Published: (2025-04-01)

Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in Australian Hospitals
by: Ian R. Woodcock, et al.
Published: (2025-04-01)

Adult spinal muscular atrophy: problems of early diagnosis
by: Yu. A. Shpilyukova, et al.
Published: (2022-12-01)

Diagnostic criteria for spinal muscular atrophy 5q
by: I. V. Sharkova, et al.
Published: (2021-12-01)

Analysis of Eye Movements in Adults with Spinal Muscular Atrophy
by: Marek Krivošík, et al.
Published: (2025-03-01)

The social-economic burden of spinal muscular atrophy in Russia
by: A. S. Kolbin, et al.
Published: (2021-02-01)

The evolution and future of respiratory care for Spinal Muscular Atrophy
by: Carrie K Barker, et al.
Published: (2025-03-01)

The Relevance of Spinal Muscular Atrophy Biomarkers in the Treatment Era
by: Marianna Maretina, et al.
Published: (2024-10-01)

Spinal muscular atrophy is also a disorder of spermatogenesis
by: Armelle Magot, et al.
Published: (2024-12-01)

A cost-utility analysis of newborn screening for spinal muscular atrophy in Canada
by: Alex Pace, et al.
Published: (2025-08-01)

Spinal muscular atrophy in the era of newborn screening: how the classification could change
by: Antonio Varone, et al.
Published: (2025-05-01)

An Item Response Theory Model for Functional Assessment of Spinal Muscular Atrophy Based on the Hammersmith Functional Motor Scale Expanded
by: FAN Yabei, et al.
Published: (2024-12-01)

The assessing of clinical relevance of chromosomal microarray analysis in the prenatal diagnosis of fetal growth restriction
by: Peng Li, et al.
Published: (2025-02-01)

Dificuldades diagnósticas na atrofia muscular espinhal Spinal muscular atrophy diagnostic difficulties
by: Alexandra Prufer de Q-C. Araújo, et al.
Published: (2005-03-01)

P841: Prenatal diagnosis of chromosomal abnormalities using QF-PCR and chromosomal microarray analysis at a single center
by: Subhas Saha, et al.
Published: (2025-01-01)

Economic burden of spinal muscular atrophy: an analysis of claims data
by: Lisa Belter, et al.
Published: (2020-01-01)

Therapy Development for Spinal Muscular Atrophy in SMN Independent Targets
by: Li-Kai Tsai
Published: (2012-01-01)

ECG tremors and polyminimyoclonus of spinal muscular atrophyType-III
by: Pradeep Kumar Gunasekaran, et al.
Published: (2023-11-01)

Rehabilitation management for patients with spinal muscular atrophy: a review
by: Wei Song, et al.
Published: (2025-07-01)

Health economic evaluation of risdiplam in patients with spinal muscular atrophy
by: А. S. Kolbin, et al.
Published: (2021-10-01)

Approaches to pathogenetic therapy of spinal muscular atrophy in children and newborns
by: S. B. Artemyeva, et al.
Published: (2024-03-01)

Factors modifying the course of spinal muscular atrophy 5q
by: M. A. Akhkiamova, et al.
Published: (2024-01-01)